HRSA-26-011: Teaching Health Center Graduate Medical Education (THCGME) Program
Closed
This grant is closed. A newer notice from the same program is open now: Teaching Health Center Graduate Medical Education (THCGME) Program (HRSA-27-017). Status: Closes December 11, 2026 (34 days left). It is in our archive of Health Resources and Services Administration notices from 2025.
Health Resources and Services Administration offered grants of up to $3.8 million (at least $160,000) to the applicants described in the notice. It expected to make about 43 awards worth $47.6 million in total. Applications closed on October 20, 2025.
From the official notice on Grants.gov, last changed September 18, 2025. Checked November 7, 2026.
- Award ceiling$3.8 million
- Award floor$160,000
- Total funding$47.6 million
- Expected awards43
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HRSA-27-017 | October 29, 2026 | Closes December 11, 2026 (34 days left) | Open |
| HRSA-27-084 | July 27, 2026 | Expected deadline November 16, 2026 | Forecast |
| HRSA-25-091 | July 19, 2024 | Closed September 5, 2024 | Closed |
| HRSA-25-077 | July 19, 2024 | Closed September 20, 2024 | Closed |
| HRSA-24-051 | August 9, 2023 | Closed January 12, 2024 | Closed |
| HRSA-23-013 | August 19, 2022 | Closed October 18, 2022 | Closed |
| HRSA-22-139 | January 31, 2022 | Closed March 31, 2022 | Closed |
| HRSA-22-105 | July 23, 2021 | Closed September 21, 2021 | Closed |
Key dates
| Posted | September 18, 2025 |
|---|---|
| Deadline | October 20, 2025 |
| Archived by Grants.gov | November 19, 2025 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility:Current THCGME Program payment recipients that were awarded funding under HRSA-22-105 and HRSA-22-139, that operate accredited primary care residency programs, or have formed a graduate medical education (GME) consortium that operates an accredited primary care residency program, in one of the following specialties/disciplines:• Family Medicine• Internal Medicine• Pediatrics• Internal Medicine-Pediatrics• Obstetrics and Gynecology• Psychiatry• General Dentistry• Pediatric Dentistry• GeriatricsExisting HRSA THCGME Program payment recipients must continue to meet eligibility criteria to remain eligible for HRSA THCGME funding. Program payment recipients that fail to meet any eligibility criteria will not be considered for funding under this announcement.
Is this a realistic fit?
- Past Teaching Health Center Graduate Medical Education Payment awards averaged $2.9 million; this notice allows up to $3.8 million per award.
- No cost sharing or match is required.
What the grant funds
The purpose of the THCGME Program is to provide funding to support the training of residents in primary care residency training programs in community-based ambulatory patient care centers. These programs will prepare residents to provide high quality care, particularly in rural and underserved communities, and develop competencies to serve a wide range of populations and communities.
Who has won Teaching Health Center Graduate Medical Education Payment grants before
From fiscal 2021 to 2025, Teaching Health Center Graduate Medical Education Payment (93.530) awarded $966 million across 335 grant awards, an average of $2.9 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Wright Center for Graduate Medical Education | Pennsylvania | 21 | $115 million |
| Osteopathic Medical Education Consortium of Oklahoma, Inc | Oklahoma | 20 | $80.2 million |
| Detroit Wayne County Health Authority | Michigan | 12 | $68.9 million |
| Cahaba Medical Care Foundation | Alabama | 9 | $49.1 million |
| Sac Health System | California | 12 | $36.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-017, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-26-011 still open?
No. It closed on October 20, 2025. A newer notice is open: HRSA-27-017, closes December 11, 2026 (34 days left).
Who can apply for Teaching Health Center Graduate Medical Education (THCGME) Program?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Teaching Health Center Graduate Medical Education (THCGME) Program?
Closed October 20, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $3.8 million each. About $47.6 million in total across about 43 awards.
Who has won Teaching Health Center Graduate Medical Education Payment grants before?
The largest recipients over five fiscal years were The Wright Center for Graduate Medical Education, Osteopathic Medical Education Consortium of Oklahoma, Inc, Detroit Wayne County Health Authority. The program made 335 awards worth $966 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)